Serum galectin-3 level was significantly higher in the patients with liver failure compared to the healthy volunteers (MD = 0.44, 95% CI = 0.23–0.66, p < 0.001) with a significant heterogeneity (I2 = 97.8%, p < 0.001). This evidence concerns the gene LGALS3 and Hepatic failure.